Nucleoprotein Nanostructures Combined with Adjuvants Adapted to the Neonatal Immune Context: A Candidate Mucosal RSV Vaccine

BACKGROUND: The human respiratory syncytial virus (hRSV) is the leading cause of severe bronchiolitis in infants worldwide. The most severe RSV diseases occur between 2 and 6 months-of-age, so pediatric vaccination will have to be started within the first weeks after birth, when the immune system is...

Descripción completa

Detalles Bibliográficos
Autores principales: Remot, Aude, Roux, Xavier, Dubuquoy, Catherine, Fix, Jenna, Bouet, Stephan, Moudjou, Mohammed, Eléouët, Jean-François, Riffault, Sabine, Petit-Camurdan, Agnès
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359995/
https://www.ncbi.nlm.nih.gov/pubmed/22655066
http://dx.doi.org/10.1371/journal.pone.0037722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359995/
https://www.ncbi.nlm.nih.gov/pubmed/22655066
http://dx.doi.org/10.1371/journal.pone.0037722

Ejemplares similares